DR. REDDYS LAB Plunges by 20%; BSE HEALTHCARE Index Down 4.0%
February 15, 2019 10:22 AM

DR. REDDYS LAB share price has plunged 20% and is presently trading at Rs 2,650.

Meanwhile, the BSE HEALTHCARE Index is at 13,738 (down 4.0%).

Among the top losers in the BSE HEALTHCARE Index today is DR. REDDYS LAB (down 19.6%).

DR. LAL PATHLABS LTD (up 1.0%) and FORTIS HEALTHCARE (up 1.0%) are among the top gainers today.

Over the last one year, DR. REDDYS LAB has moved up from Rs 2,183 to Rs 2,650, registering a gain of Rs 467 (up 21.4%)..

The BSE HEALTHCARE has moved down from 14,417 to 13,738, loss of 679 points (down 4.7%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were DIVIS LABORATORIES (up 49.2%), ABBOTT INDIA (up 31.8%) and SANOFI INDIA (up 28.6%).

What About the Benchmark Indices?

The BSE Sensex is at 36,023 (down 0.4%). The top gainers among the BSE Sensex stocks today are ONGC (up 6.0%). The most traded stocks in the BSE Sensex are ONGC and ICICI BANK.

In the meantime, NSE Nifty is at 10,786 (down 0.5%). ONGC (up 6.0%) is among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 34,156 to 36,023, registering a gain of 1,867 points (up 4.6%).

DR. REDDYS LAB Financial Update...

DR. REDDYS LAB net profit stood at Rs 5 billion for the quarter ended December 2018, compared to a profit of Rs 3 billion a year ago. Net Sales rose 0.8% to Rs 38.6 billion during the period as against Rs 38.3 billion in October-December 2017.

For the year ended March 2018, DR. REDDYS LAB reported 27.4% decrease in net profit to Rs 9.1 billion compared to net profit of Rs 12.6 billion during FY17.

Revenue of the company grew 0.6% to Rs 143 billion during FY18.

The current Price to earnings ratio of DR. REDDYS LAB, based on rolling 12 month earnings, stands at 20.4x.